nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenazopyridine—SCN7A—Interaction between L1 and Ankyrins—SPTBN4—polycystic ovary syndrome	0.0466	0.0636	CbGpPWpGaD
Phenazopyridine—SCN11A—Interaction between L1 and Ankyrins—SPTBN4—polycystic ovary syndrome	0.0416	0.0567	CbGpPWpGaD
Phenazopyridine—SCN8A—Interaction between L1 and Ankyrins—SPTBN4—polycystic ovary syndrome	0.038	0.0518	CbGpPWpGaD
Phenazopyridine—SCN9A—Interaction between L1 and Ankyrins—SPTBN4—polycystic ovary syndrome	0.0308	0.0419	CbGpPWpGaD
Phenazopyridine—SCN3A—Interaction between L1 and Ankyrins—SPTBN4—polycystic ovary syndrome	0.0294	0.0401	CbGpPWpGaD
Phenazopyridine—SCN4A—Interaction between L1 and Ankyrins—SPTBN4—polycystic ovary syndrome	0.0283	0.0385	CbGpPWpGaD
Phenazopyridine—SCN2A—Interaction between L1 and Ankyrins—SPTBN4—polycystic ovary syndrome	0.0283	0.0385	CbGpPWpGaD
Phenazopyridine—SCN10A—Interaction between L1 and Ankyrins—SPTBN4—polycystic ovary syndrome	0.0272	0.0371	CbGpPWpGaD
Phenazopyridine—SCN1A—Interaction between L1 and Ankyrins—SPTBN4—polycystic ovary syndrome	0.0272	0.0371	CbGpPWpGaD
Phenazopyridine—SCN7A—adipose tissue—polycystic ovary syndrome	0.0195	0.0732	CbGeAlD
Phenazopyridine—SCN5A—Interaction between L1 and Ankyrins—SPTBN4—polycystic ovary syndrome	0.0192	0.0261	CbGpPWpGaD
Phenazopyridine—SCN7A—L1CAM interactions—SPTBN4—polycystic ovary syndrome	0.0179	0.0244	CbGpPWpGaD
Phenazopyridine—SCN7A—adrenal gland—polycystic ovary syndrome	0.0175	0.0656	CbGeAlD
Phenazopyridine—SCN7A—female gonad—polycystic ovary syndrome	0.0163	0.0612	CbGeAlD
Phenazopyridine—SCN11A—L1CAM interactions—SPTBN4—polycystic ovary syndrome	0.016	0.0217	CbGpPWpGaD
Phenazopyridine—SCN9A—pituitary gland—polycystic ovary syndrome	0.0153	0.0576	CbGeAlD
Phenazopyridine—SCN9A—adipose tissue—polycystic ovary syndrome	0.0153	0.0573	CbGeAlD
Phenazopyridine—SCN7A—endocrine gland—polycystic ovary syndrome	0.0152	0.0569	CbGeAlD
Phenazopyridine—SCN8A—L1CAM interactions—SPTBN4—polycystic ovary syndrome	0.0146	0.0199	CbGpPWpGaD
Phenazopyridine—SCN9A—adrenal gland—polycystic ovary syndrome	0.0137	0.0514	CbGeAlD
Phenazopyridine—SCN4A—pituitary gland—polycystic ovary syndrome	0.0137	0.0514	CbGeAlD
Phenazopyridine—SCN4A—adipose tissue—polycystic ovary syndrome	0.0136	0.0511	CbGeAlD
Phenazopyridine—SCN8A—endocrine gland—polycystic ovary syndrome	0.0135	0.0507	CbGeAlD
Phenazopyridine—SCN4A—adrenal gland—polycystic ovary syndrome	0.0122	0.0459	CbGeAlD
Phenazopyridine—SCN2A—pituitary gland—polycystic ovary syndrome	0.0121	0.0454	CbGeAlD
Phenazopyridine—SCN9A—L1CAM interactions—SPTBN4—polycystic ovary syndrome	0.0118	0.0161	CbGpPWpGaD
Phenazopyridine—SCN10A—pituitary gland—polycystic ovary syndrome	0.0117	0.0438	CbGeAlD
Phenazopyridine—SCN3A—L1CAM interactions—SPTBN4—polycystic ovary syndrome	0.0113	0.0154	CbGpPWpGaD
Phenazopyridine—SCN4A—L1CAM interactions—SPTBN4—polycystic ovary syndrome	0.0108	0.0148	CbGpPWpGaD
Phenazopyridine—SCN2A—L1CAM interactions—SPTBN4—polycystic ovary syndrome	0.0108	0.0148	CbGpPWpGaD
Phenazopyridine—SCN3A—pituitary gland—polycystic ovary syndrome	0.0106	0.0399	CbGeAlD
Phenazopyridine—SCN3A—adipose tissue—polycystic ovary syndrome	0.0106	0.0398	CbGeAlD
Phenazopyridine—SCN1A—L1CAM interactions—SPTBN4—polycystic ovary syndrome	0.0105	0.0143	CbGpPWpGaD
Phenazopyridine—SCN10A—L1CAM interactions—SPTBN4—polycystic ovary syndrome	0.0105	0.0143	CbGpPWpGaD
Phenazopyridine—SCN2A—vagina—polycystic ovary syndrome	0.01	0.0376	CbGeAlD
Phenazopyridine—SCN3A—adrenal gland—polycystic ovary syndrome	0.0095	0.0357	CbGeAlD
Phenazopyridine—SCN2A—endocrine gland—polycystic ovary syndrome	0.00937	0.0352	CbGeAlD
Phenazopyridine—SCN10A—endocrine gland—polycystic ovary syndrome	0.00904	0.0339	CbGeAlD
Phenazopyridine—SCN3A—vagina—polycystic ovary syndrome	0.00881	0.0331	CbGeAlD
Phenazopyridine—SCN5A—vagina—polycystic ovary syndrome	0.00878	0.033	CbGeAlD
Phenazopyridine—SCN5A—L1CAM interactions—SPTBN4—polycystic ovary syndrome	0.00735	0.01	CbGpPWpGaD
Phenazopyridine—SCN7A—L1CAM interactions—DLG4—polycystic ovary syndrome	0.00707	0.00964	CbGpPWpGaD
Phenazopyridine—SCN7A—Axon guidance—SPTBN4—polycystic ovary syndrome	0.00676	0.00922	CbGpPWpGaD
Phenazopyridine—SCN11A—L1CAM interactions—DLG4—polycystic ovary syndrome	0.0063	0.00859	CbGpPWpGaD
Phenazopyridine—SCN11A—Axon guidance—SPTBN4—polycystic ovary syndrome	0.00603	0.00822	CbGpPWpGaD
Phenazopyridine—SCN7A—Developmental Biology—CDH15—polycystic ovary syndrome	0.00592	0.00807	CbGpPWpGaD
Phenazopyridine—SCN8A—L1CAM interactions—DLG4—polycystic ovary syndrome	0.00576	0.00786	CbGpPWpGaD
Phenazopyridine—SCN8A—Axon guidance—SPTBN4—polycystic ovary syndrome	0.00551	0.00752	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—CDH15—polycystic ovary syndrome	0.00528	0.00719	CbGpPWpGaD
Phenazopyridine—SCN7A—Developmental Biology—SPTBN4—polycystic ovary syndrome	0.00483	0.00658	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—CDH15—polycystic ovary syndrome	0.00483	0.00658	CbGpPWpGaD
Phenazopyridine—SCN9A—L1CAM interactions—DLG4—polycystic ovary syndrome	0.00466	0.00635	CbGpPWpGaD
Phenazopyridine—SCN9A—Axon guidance—SPTBN4—polycystic ovary syndrome	0.00446	0.00608	CbGpPWpGaD
Phenazopyridine—SCN3A—L1CAM interactions—DLG4—polycystic ovary syndrome	0.00446	0.00608	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—SPTBN4—polycystic ovary syndrome	0.0043	0.00586	CbGpPWpGaD
Phenazopyridine—SCN2A—L1CAM interactions—DLG4—polycystic ovary syndrome	0.00428	0.00584	CbGpPWpGaD
Phenazopyridine—SCN4A—L1CAM interactions—DLG4—polycystic ovary syndrome	0.00428	0.00584	CbGpPWpGaD
Phenazopyridine—SCN3A—Axon guidance—SPTBN4—polycystic ovary syndrome	0.00427	0.00581	CbGpPWpGaD
Phenazopyridine—SCN1A—L1CAM interactions—DLG4—polycystic ovary syndrome	0.00413	0.00563	CbGpPWpGaD
Phenazopyridine—SCN10A—L1CAM interactions—DLG4—polycystic ovary syndrome	0.00413	0.00563	CbGpPWpGaD
Phenazopyridine—SCN2A—Axon guidance—SPTBN4—polycystic ovary syndrome	0.0041	0.00559	CbGpPWpGaD
Phenazopyridine—SCN4A—Axon guidance—SPTBN4—polycystic ovary syndrome	0.0041	0.00559	CbGpPWpGaD
Phenazopyridine—SCN10A—Axon guidance—SPTBN4—polycystic ovary syndrome	0.00395	0.00539	CbGpPWpGaD
Phenazopyridine—SCN1A—Axon guidance—SPTBN4—polycystic ovary syndrome	0.00395	0.00539	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—SPTBN4—polycystic ovary syndrome	0.00394	0.00536	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—CDH15—polycystic ovary syndrome	0.0039	0.00532	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—CDH15—polycystic ovary syndrome	0.00373	0.00509	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—CDH15—polycystic ovary syndrome	0.00359	0.00489	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—CDH15—polycystic ovary syndrome	0.00359	0.00489	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—CDH15—polycystic ovary syndrome	0.00346	0.00472	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—CDH15—polycystic ovary syndrome	0.00346	0.00472	CbGpPWpGaD
Phenazopyridine—SCN5A—Cardiac Progenitor Differentiation—NRG1—polycystic ovary syndrome	0.00343	0.00468	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—SPTBN4—polycystic ovary syndrome	0.00318	0.00434	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—SPTBN4—polycystic ovary syndrome	0.00304	0.00415	CbGpPWpGaD
Phenazopyridine—SCN5A—SIDS Susceptibility Pathways—RUNX3—polycystic ovary syndrome	0.00299	0.00407	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—SPTBN4—polycystic ovary syndrome	0.00292	0.00399	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—SPTBN4—polycystic ovary syndrome	0.00292	0.00399	CbGpPWpGaD
Phenazopyridine—SCN5A—L1CAM interactions—DLG4—polycystic ovary syndrome	0.0029	0.00396	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—SPTBN4—polycystic ovary syndrome	0.00282	0.00384	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—SPTBN4—polycystic ovary syndrome	0.00282	0.00384	CbGpPWpGaD
Phenazopyridine—SCN5A—Axon guidance—SPTBN4—polycystic ovary syndrome	0.00278	0.00379	CbGpPWpGaD
Phenazopyridine—SCN7A—Axon guidance—DLG4—polycystic ovary syndrome	0.00267	0.00364	CbGpPWpGaD
Phenazopyridine—SCN5A—Cardiac Progenitor Differentiation—INS—polycystic ovary syndrome	0.00246	0.00335	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—CDH15—polycystic ovary syndrome	0.00243	0.00331	CbGpPWpGaD
Phenazopyridine—SCN11A—Axon guidance—DLG4—polycystic ovary syndrome	0.00238	0.00325	CbGpPWpGaD
Phenazopyridine—SCN5A—Cardiac Progenitor Differentiation—IGF1—polycystic ovary syndrome	0.00238	0.00324	CbGpPWpGaD
Phenazopyridine—SCN8A—Axon guidance—DLG4—polycystic ovary syndrome	0.00218	0.00297	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—SPTBN4—polycystic ovary syndrome	0.00198	0.0027	CbGpPWpGaD
Phenazopyridine—SCN7A—Developmental Biology—DLG4—polycystic ovary syndrome	0.00191	0.0026	CbGpPWpGaD
Phenazopyridine—SCN5A—SIDS Susceptibility Pathways—TH—polycystic ovary syndrome	0.0019	0.00259	CbGpPWpGaD
Phenazopyridine—SCN7A—Developmental Biology—ADIPOQ—polycystic ovary syndrome	0.00189	0.00258	CbGpPWpGaD
Phenazopyridine—SCN7A—Developmental Biology—SLC2A4—polycystic ovary syndrome	0.00179	0.00244	CbGpPWpGaD
Phenazopyridine—SCN9A—Axon guidance—DLG4—polycystic ovary syndrome	0.00176	0.0024	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—DLG4—polycystic ovary syndrome	0.0017	0.00232	CbGpPWpGaD
Phenazopyridine—SCN5A—SIDS Susceptibility Pathways—AR—polycystic ovary syndrome	0.00169	0.0023	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—ADIPOQ—polycystic ovary syndrome	0.00169	0.0023	CbGpPWpGaD
Phenazopyridine—SCN3A—Axon guidance—DLG4—polycystic ovary syndrome	0.00168	0.0023	CbGpPWpGaD
Phenazopyridine—SCN2A—Axon guidance—DLG4—polycystic ovary syndrome	0.00162	0.00221	CbGpPWpGaD
Phenazopyridine—SCN4A—Axon guidance—DLG4—polycystic ovary syndrome	0.00162	0.00221	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—SLC2A4—polycystic ovary syndrome	0.00159	0.00217	CbGpPWpGaD
Phenazopyridine—SCN10A—Axon guidance—DLG4—polycystic ovary syndrome	0.00156	0.00213	CbGpPWpGaD
Phenazopyridine—SCN1A—Axon guidance—DLG4—polycystic ovary syndrome	0.00156	0.00213	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—DLG4—polycystic ovary syndrome	0.00155	0.00212	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—ADIPOQ—polycystic ovary syndrome	0.00154	0.0021	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—SLC2A4—polycystic ovary syndrome	0.00146	0.00199	CbGpPWpGaD
Phenazopyridine—SCN7A—Developmental Biology—NCOR1—polycystic ovary syndrome	0.00143	0.00195	CbGpPWpGaD
Phenazopyridine—SCN5A—SIDS Susceptibility Pathways—NR3C1—polycystic ovary syndrome	0.00136	0.00186	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—NCOR1—polycystic ovary syndrome	0.00127	0.00174	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—DLG4—polycystic ovary syndrome	0.00126	0.00171	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—ADIPOQ—polycystic ovary syndrome	0.00125	0.0017	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—DLG4—polycystic ovary syndrome	0.0012	0.00164	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—ADIPOQ—polycystic ovary syndrome	0.00119	0.00163	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—SLC2A4—polycystic ovary syndrome	0.00118	0.00161	CbGpPWpGaD
Phenazopyridine—SCN7A—Developmental Biology—LEP—polycystic ovary syndrome	0.00118	0.0016	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—NCOR1—polycystic ovary syndrome	0.00116	0.00159	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—DLG4—polycystic ovary syndrome	0.00116	0.00157	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—DLG4—polycystic ovary syndrome	0.00116	0.00157	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—ADIPOQ—polycystic ovary syndrome	0.00115	0.00156	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—ADIPOQ—polycystic ovary syndrome	0.00115	0.00156	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—SLC2A4—polycystic ovary syndrome	0.00113	0.00154	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—DLG4—polycystic ovary syndrome	0.00111	0.00152	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—DLG4—polycystic ovary syndrome	0.00111	0.00152	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—ADIPOQ—polycystic ovary syndrome	0.00111	0.00151	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—ADIPOQ—polycystic ovary syndrome	0.00111	0.00151	CbGpPWpGaD
Phenazopyridine—SCN5A—Axon guidance—DLG4—polycystic ovary syndrome	0.0011	0.0015	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—SLC2A4—polycystic ovary syndrome	0.00108	0.00148	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—SLC2A4—polycystic ovary syndrome	0.00108	0.00148	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—LEP—polycystic ovary syndrome	0.00105	0.00143	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—SLC2A4—polycystic ovary syndrome	0.00104	0.00142	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—SLC2A4—polycystic ovary syndrome	0.00104	0.00142	CbGpPWpGaD
Phenazopyridine—SCN7A—Developmental Biology—PPARG—polycystic ovary syndrome	0.00102	0.0014	CbGpPWpGaD
Phenazopyridine—SCN7A—Developmental Biology—INS—polycystic ovary syndrome	0.001	0.00137	CbGpPWpGaD
Phenazopyridine—SCN7A—Developmental Biology—AKT2—polycystic ovary syndrome	0.00097	0.00132	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—LEP—polycystic ovary syndrome	0.000958	0.00131	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—NCOR1—polycystic ovary syndrome	0.000942	0.00128	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—PPARG—polycystic ovary syndrome	0.000912	0.00124	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—NCOR1—polycystic ovary syndrome	0.000901	0.00123	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—INS—polycystic ovary syndrome	0.000895	0.00122	CbGpPWpGaD
Phenazopyridine—SCN7A—Axon guidance—VEGFA—polycystic ovary syndrome	0.000889	0.00121	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—NCOR1—polycystic ovary syndrome	0.000865	0.00118	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—NCOR1—polycystic ovary syndrome	0.000865	0.00118	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—AKT2—polycystic ovary syndrome	0.000865	0.00118	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—NCOR1—polycystic ovary syndrome	0.000834	0.00114	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—PPARG—polycystic ovary syndrome	0.000834	0.00114	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—NCOR1—polycystic ovary syndrome	0.000834	0.00114	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—INS—polycystic ovary syndrome	0.000818	0.00112	CbGpPWpGaD
Phenazopyridine—SCN11A—Axon guidance—VEGFA—polycystic ovary syndrome	0.000792	0.00108	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—AKT2—polycystic ovary syndrome	0.000791	0.00108	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—DLG4—polycystic ovary syndrome	0.000783	0.00107	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—ADIPOQ—polycystic ovary syndrome	0.000777	0.00106	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—LEP—polycystic ovary syndrome	0.000775	0.00106	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—LEP—polycystic ovary syndrome	0.000741	0.00101	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—SLC2A4—polycystic ovary syndrome	0.000734	0.001	CbGpPWpGaD
Phenazopyridine—SCN8A—Axon guidance—VEGFA—polycystic ovary syndrome	0.000725	0.000988	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—LEP—polycystic ovary syndrome	0.000712	0.00097	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—LEP—polycystic ovary syndrome	0.000712	0.00097	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—LEP—polycystic ovary syndrome	0.000687	0.000936	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—LEP—polycystic ovary syndrome	0.000687	0.000936	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—PPARG—polycystic ovary syndrome	0.000675	0.00092	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—INS—polycystic ovary syndrome	0.000662	0.000902	CbGpPWpGaD
Phenazopyridine—SCN5A—SIDS Susceptibility Pathways—VEGFA—polycystic ovary syndrome	0.000655	0.000893	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—PPARG—polycystic ovary syndrome	0.000645	0.00088	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—AKT2—polycystic ovary syndrome	0.00064	0.000872	CbGpPWpGaD
Phenazopyridine—SCN7A—Developmental Biology—VEGFA—polycystic ovary syndrome	0.000634	0.000864	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—INS—polycystic ovary syndrome	0.000633	0.000863	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—PPARG—polycystic ovary syndrome	0.00062	0.000845	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—PPARG—polycystic ovary syndrome	0.00062	0.000845	CbGpPWpGaD
Phenazopyridine—SCN7A—Axon guidance—IL6—polycystic ovary syndrome	0.000615	0.000838	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—AKT2—polycystic ovary syndrome	0.000612	0.000834	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—INS—polycystic ovary syndrome	0.000608	0.000829	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—INS—polycystic ovary syndrome	0.000608	0.000829	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—PPARG—polycystic ovary syndrome	0.000598	0.000815	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—PPARG—polycystic ovary syndrome	0.000598	0.000815	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—AKT2—polycystic ovary syndrome	0.000588	0.000801	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—AKT2—polycystic ovary syndrome	0.000588	0.000801	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—NCOR1—polycystic ovary syndrome	0.000587	0.0008	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—INS—polycystic ovary syndrome	0.000587	0.000799	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—INS—polycystic ovary syndrome	0.000587	0.000799	CbGpPWpGaD
Phenazopyridine—SCN9A—Axon guidance—VEGFA—polycystic ovary syndrome	0.000586	0.000799	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—AKT2—polycystic ovary syndrome	0.000567	0.000773	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—AKT2—polycystic ovary syndrome	0.000567	0.000773	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—VEGFA—polycystic ovary syndrome	0.000565	0.00077	CbGpPWpGaD
Phenazopyridine—SCN3A—Axon guidance—VEGFA—polycystic ovary syndrome	0.000561	0.000764	CbGpPWpGaD
Phenazopyridine—SCN11A—Axon guidance—IL6—polycystic ovary syndrome	0.000548	0.000747	CbGpPWpGaD
Phenazopyridine—SCN2A—Axon guidance—VEGFA—polycystic ovary syndrome	0.000539	0.000734	CbGpPWpGaD
Phenazopyridine—SCN4A—Axon guidance—VEGFA—polycystic ovary syndrome	0.000539	0.000734	CbGpPWpGaD
Phenazopyridine—SCN10A—Axon guidance—VEGFA—polycystic ovary syndrome	0.000519	0.000708	CbGpPWpGaD
Phenazopyridine—SCN1A—Axon guidance—VEGFA—polycystic ovary syndrome	0.000519	0.000708	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—VEGFA—polycystic ovary syndrome	0.000517	0.000705	CbGpPWpGaD
Phenazopyridine—SCN8A—Axon guidance—IL6—polycystic ovary syndrome	0.000501	0.000683	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—LEP—polycystic ovary syndrome	0.000483	0.000658	CbGpPWpGaD
Phenazopyridine—SCN5A—SIDS Susceptibility Pathways—IL6—polycystic ovary syndrome	0.000453	0.000618	CbGpPWpGaD
Phenazopyridine—SCN7A—Developmental Biology—IL6—polycystic ovary syndrome	0.000439	0.000598	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—PPARG—polycystic ovary syndrome	0.00042	0.000573	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—VEGFA—polycystic ovary syndrome	0.000418	0.00057	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—INS—polycystic ovary syndrome	0.000412	0.000562	CbGpPWpGaD
Phenazopyridine—SCN9A—Axon guidance—IL6—polycystic ovary syndrome	0.000405	0.000552	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—VEGFA—polycystic ovary syndrome	0.0004	0.000545	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—AKT2—polycystic ovary syndrome	0.000399	0.000543	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—IL6—polycystic ovary syndrome	0.000391	0.000533	CbGpPWpGaD
Phenazopyridine—SCN3A—Axon guidance—IL6—polycystic ovary syndrome	0.000388	0.000528	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—VEGFA—polycystic ovary syndrome	0.000384	0.000524	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—VEGFA—polycystic ovary syndrome	0.000384	0.000524	CbGpPWpGaD
Phenazopyridine—SCN2A—Axon guidance—IL6—polycystic ovary syndrome	0.000372	0.000508	CbGpPWpGaD
Phenazopyridine—SCN4A—Axon guidance—IL6—polycystic ovary syndrome	0.000372	0.000508	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—VEGFA—polycystic ovary syndrome	0.000371	0.000505	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—VEGFA—polycystic ovary syndrome	0.000371	0.000505	CbGpPWpGaD
Phenazopyridine—SCN5A—Axon guidance—VEGFA—polycystic ovary syndrome	0.000365	0.000498	CbGpPWpGaD
Phenazopyridine—SCN10A—Axon guidance—IL6—polycystic ovary syndrome	0.000359	0.000489	CbGpPWpGaD
Phenazopyridine—SCN1A—Axon guidance—IL6—polycystic ovary syndrome	0.000359	0.000489	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—IL6—polycystic ovary syndrome	0.000358	0.000487	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—IL6—polycystic ovary syndrome	0.000289	0.000394	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—IL6—polycystic ovary syndrome	0.000277	0.000377	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—IL6—polycystic ovary syndrome	0.000266	0.000362	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—IL6—polycystic ovary syndrome	0.000266	0.000362	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—VEGFA—polycystic ovary syndrome	0.000261	0.000355	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—IL6—polycystic ovary syndrome	0.000256	0.000349	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—IL6—polycystic ovary syndrome	0.000256	0.000349	CbGpPWpGaD
Phenazopyridine—SCN5A—Axon guidance—IL6—polycystic ovary syndrome	0.000252	0.000344	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—IL6—polycystic ovary syndrome	0.00018	0.000246	CbGpPWpGaD
